Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.
Patients with vitiligo often have antibodies to pigment cells. To examine whether there is a relation between the presence of such antibodies and disease activity, sera of 24 patients with vitiligo (10 with active and 14 with inactive disease) and 19 normal individuals were tested for antibodies to pigment cell surface antigens using a live cell enzyme-linked immunoabsorbent assay. IgG pigment cell antibodies were present in 80% (eight of 10) of patients with active vitiligo but in none of those with inactive disease or in normal individuals. The antibody level of patients with active vitiligo (mean binding index [BI] 3.3 +/- 0.59) was significantly higher than in patients with inactive disease (BI 0.96 +/- 0.04) or normal individuals (BI 1.0 +/- 0.04, p less than 0.001). Antibodies present in eight patients with high titers of pigment cell antibodies reacted to three of four pigment cells but to only one of six unrelated cells. These findings indicate that a correlation exists between the incidence and level of pigment cell antibodies and the activity of vitiligo, and support the hypothesis that vitiligo is an autoimmune disease mediated by an immune reaction to pigment cells.
Harning
R
R
Department of Immunology, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut.
Cui
J
J
Bystryn
J C
JC
D000906:Antibodies / Q000032:analysis*; D006801:Humans; D008544:Melanocytes / Q000276:immunology*; D014820:Vitiligo / Q000276:immunology* / Q000503:physiopathology
D000906:Antibodies